Eris Lifesciences has informed that the meeting of the Board of Directors of the Company is scheduled on 24/11/2025 to consider and approve issuance of equity shares of the Company by way of a preferential issue for consideration other than cash.
The above information is a part of company’s filings submitted to BSE.